Advertisement

 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links

advertisement.gif (61x7 -- 0 bytes)

   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 

 

 

Back to index

Cancer Chemotherapy Regimen for Lymphoma Cancer


 COP-BLAM                                             lymphoma(90)
 _________________________________________________________________
  cytoxan......... 400 mg/sqm IV day 1.
  vincristine..... 1.0 mg/sqm IV day 1.
  prednisone...... 40 mg/sqm/day orally from day 1 to day 10.
  bleomycin....... 15 U IV day 14.
  adriamycin...... 40 mg/sqm IV day 1.
  procarbazine.... 100 mg/sqm/day orally from day 1 to 10.
  FREQUENCY....... Repeat cycle every 21 days.


  reference...
    Laurence J.  Coleman M.  Allen SL.  Silver RT.  Pasmantier M. 
    Combination chemotherapy of advanced diffuse histiocytic 
    lymphoma with the six-drug COP-BLAM regimen. Annals of 
    Internal Medicine.  97(2):190-5, 1982 Aug. 
  abstract...
    A new multiple-drug protocol consisting of cyclophosphamide, 
    vincristine, prednisone, bleomycin, doxorubicin, and 
    procarbazine, known as COP-BLAM, was administered to 48 
    patients with stage III or IV diffuse histiocytic lymphoma. 
    Twenty-four of the 33 previously untreated patients had a 
    complete remission, and eight patients had a partial response. 
    The median survival for all previously untreated patients has 
    not yet been reached at 23 months. Median survival for complte 
    responders has not yet been attained at 26 months, although 
    survival of partial responders is 12.5 months. There were no 
    patients with a complete response who had a central nervous 
    system relapse. The COP-BLAM therapy is an easily administered 
    outpatient program capable of inducing a high frequency of 
    durable complete remissions in advanced diffuse histiocytic 
    lymphoma, a malignancy formerly considered to have a poor 
    prognosis. 
 

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


 

 advertisement.gif (61x7 -- 0 bytes)

 

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright © 2001-2007 The Doctors Lounge. All rights reserved.